We can assess the patient’s tumor burden and disease progression based on biochemical indicators (e.g., hemoglobin, serum calcium, β2-microglobulin(β2M), serum albumin, lactate dehydrogenase(LDH)) to determine the stage of the disease (4). Here, B2M is linked to neoplasm.